Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial

BACKGROUND: Nucleot(s)ide analog treatment (entecavir (ETV) and tenofovir (TDF)) is reported to be associated with decreased tumor recurrence and death in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients, yet further work is needed to evaluate the different efficacies of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Linye, He, Zijing, Xia, Xiaoyun, Zhang, Zhihui, Li, Tianfu, Wen, Chuan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583900/
https://www.ncbi.nlm.nih.gov/pubmed/37335984
http://dx.doi.org/10.1097/JS9.0000000000000554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583900/
https://www.ncbi.nlm.nih.gov/pubmed/37335984
http://dx.doi.org/10.1097/JS9.0000000000000554

Ejemplares similares